Equillium & Biocon Expand Exclusive Licensing Agreement For Itolizumab To Include Australia And New Zealand Read more
Exclusive Interview From HK Packaging Consulting Speaker Released For SMi’s Pre-Filled Syringes 2020 Conference Read more
Dr Samareh Lajaunias, Director At Combioxin Speaking At SMi’s 22nd Annual Superbugs & Superdrugs Conference Read more
Invite From Lynne Ensor Chair For Pharma Microbiology East Coast Conference, April 2020, Boston Read more
Regeneron and Sanofi Announce Intent to Restructure Antibody Collaboration for Kevzara and Praluent Read more
Amneal to Acquire Majority Interest in AvKARE, Enhancing Access to Growing Federal Healthcare Market Read more
Flagship Pioneering Unveils Cellarity, The First Company To Discover Medicines Targeting Cell Behavior Read more
Dermira Receives Fast Track Designation From FDA For Lebrikizumab For The Treatment Of Atopic Dermatitis Read more
Retrogenix And Resonant Therapeutics Announce Strategic Alliance To Identify Targets Of Anti-Tumor Antibodies Read more